Abbott forced to halt infant-formula production again due to flooding
Last week it said it expected to resume shipments of formula manufactured at the plant “on or about” 20 June.
ByAbbott Laboratories
Abbott infant-formula shipments expected in two weeks as Michigan factory reopens
Abbott reopened its Sturgis factory on Saturday and expects to begin shipments on 20 June.
By US FDA concedes below-par response to infant-formula crisis
Abbott aims for early June opening of Sturgis formula plant amid US House grilling.
By Federal Trade Commission launches inquiry into US infant-formula crisis
The inquiry aims to “shed light on the factors that have led to concentration in the infant-formula market.
By Abbott enters “corrective action” decree with FDA to get Sturgis formula plant running again
Abbott warned it could take six to eight weeks to get product back on shelves.
By Abbott eyes May return to production at under-scrutiny plant
Abbott Laboratories has said production at its under-scrutiny infant-formula factory could start within a fortnight. Output at the US group’s…
By
US FDA moves to boost supply of specialist infant formula
The regulator tries to reassure parents amid reports of shortages of specialised products critical in keeping some infants fed.
By
Infant-formula firm Abbott to release products halted after salmonella-linked recall
It is releasing limited quantities of metabolic nutrition formulas that were previously on hold.
By